Discover how OS Therapies' immunotherapy, OST-HER2, originally developed for canine osteosarcoma, shows promising results in fast-tracking treatments for human osteosarcoma. Learn about comparative ...

Background: To report the outcomes of computer-aided resection and endoprosthesis design for the management of malignant bone tumors around the knee. Methods: Computed tomography (CT) and magnetic ...

Expert Rev Anticancer Ther. 2009;9(4):511-523. With current standard treatment, including multiagent chemotherapy and surgical resection, 70% of patients with localized osteosarcoma are cured.

Herein, we report a 73-year-old man with an acquired ALK-rearranged osteosarcoma. With targeted therapy, the patient showed prolonged disease stabilization of his previously progressing tumor.